David P. Fritsche

David P.
Fritsche
MBA
Technology Officer, Learning Ecosystems Accelerator for Patient-centered & Sustainable (LEAPS) Innovation Project

David (Dave) Fritsche is the Technology Officer for the LEAPS program, leading the effort to identify, evaluate and implement appropriate technologies to support the LEAPS initiative.  Dave is also founder and Managing Director of Pantograph Group, providing IT strategy and consulting for the biopharma industry.  Prior to joining the LEAPS program, Dave worked at ARIAD Pharmaceuticals as Vice President, Global Head of IT for the Clinical through Commercial business areas. He was responsible for the information systems supporting patient access to treatments through the functions of clinical development, medical affairs, pharmacovigilance, and commercial operations.  Prior to joining ARIAD, Mr. Fritsche served as Sanofi’s Global IT Business Partner in support of scientific core platforms, including lead compound generation, pharmaceutical development, preclinical, and clinical.  Prior to that, he co-led the data migration of all Genzyme and Sanofi-Pasteur safety data into the global Sanofi pharmacovigilance system.  Previously, Mr. Fritsche was with Genzyme for ten years.  Starting with EDC implementations for clinical trials and culminating with deployment of an industry-recognized platform for rare disease registries, he steadily gained responsibility for systems supporting clinical development, registration and post-marketing support.  Mr. Fritsche earned a B.A. in Computer Science from the University of Delaware and an M.B.A. in Marketing from the University of Rochester.